Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399750 · ClinicalTrials.gov registry record · Phase 2
TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer
A Phase 2 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 2
- Development phase
- 373
- Enrollment target
NCT00399750: Completed Phase 2 study, sponsored by Sanofi.
NCT00399750 is a Phase 2 study that has completed, run by Sanofi. The registered enrollment target is 373 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (180% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00399750, a Phase 2 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 373 participants
- Enrollment target
Study Summary
A randomized, controlled, open-label multicenter trial to assess the safety and efficacy of 3 oxaliplatin-fluoropyrimidine containing regimens (mFOLFOX6; bFOL; XELOX) + Bevacizumab (TREE1 and TREE2) as first line therapy of advanced metastatic colorectal cancer.
Interventions
- DRUG bevacizumab
- DRUG oxaliplatin
- DRUG fluoropyrimidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
What the finished NCT00399750 record still lists
NCT00399750 is an interventional study that assigns participants to a tested intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (180% higher).
The record links to 0 conditions, and to 3 interventions - of which bevacizumab is the first listed.
NCT00399750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00399750 about?
NCT00399750 is a clinical study titled "TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer". A randomized, controlled, open-label multicenter trial to assess the safety and efficacy of 3 oxaliplatin-fluoropyrimidine containing regimens (mFOLFOX6; bFOL; XELOX) + Bevacizumab (TREE1 and TREE2) as first line therapy of advanced metastatic colorectal cancer.
What is the current status of trial NCT00399750?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 373 participants. The study started on 2002-11. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00399750?
The interventions under investigation include: bevacizumab (DRUG), oxaliplatin (DRUG), fluoropyrimidine (DRUG).
Who is sponsoring clinical trial NCT00399750?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00399750's enrollment target sits among peer trials
373 118th of 2000 higher than 1,883 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07276750 · 373 participants · NA
Coaching and Leadership in Autism Support Settings
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia